Pacific Biosciences of California, Inc. (PACB) compared with its closest peers (ALMR, CTKB, EYPT, MASS, HBIO). Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.40B | — |
| Cytek Biosciences, Inc. (CTKB) | $605.07M | -9.7 |
| EyePoint Pharmaceuticals, Inc. (EYPT) | $466.41M | -5.8 |
| 908 Devices Inc. (MASS) | $426.56M | 9.7 |
| Harvard Bioscience, Inc. (HBIO) | $159.48M | -0.5 |
| Quanterix Corporation (QTRX) | $147.55M | -2.5 |
| Nautilus Biotechnology, Inc. (NAUT) | $114.35M | -4.1 |
| Seer, Inc. (SEER) | $111.85M | -1.4 |
| Rapid Micro Biosystems, Inc. (RPID) | $80.74M | -2.7 |
| Precipio, Inc. (PRPO) | $51.90M | -102.4 |
| Sector P/E (Technology) | 33.9 |
| Industry P/E (Measuring & Control Equipment) | 51.8 |
PACB overview · PACB earnings · PACB financials · PACB KPIs · PACB investor relations · PACB ownership · PACB filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.